Drug intelligence / Profile preview

Fenamole

Development stage: Unknown
Modality: Small Molecules
Administration: Intravenous, Intramuscular, Transdermal, Intranasal, Buccal, Sublingual, Oromucosal, Intrathecal, Intraosseous

Overview

Fenamole is a chemical compound with the molecular formula C7H7N5, also known as 1H-TETRAZOL-5-AMINE, 1-PHENYL- or 5-Amino-1-phenyl-1H-tetrazole. It is classified as an agent affecting the nervous system, an analgesic, a nonnarcotic analgesic, an antipyretic, and a nonsteroidal anti-inflammatory drug. Its code name is AL 0559. The precise mechanism of action and primary indications are not extensively detailed in publicly available information for this specific chemical entity.

Other names: 1H-TETRAZOL-5-AMINE, 1-PHENYL-5-Amino-1-phenyl-1H-tetrazole

Beyond the preview

Go deeper on Fenamole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fenamole.

Explore the full profile